This is an opportunity to share a challenging and instructional case on a patient with cholangiocarcinoma (CCA) or other biliary tract cancer with your colleagues. Please see below for the specific categories and the instructions for submitting the case presentation.
Please submit an outline of the case report by midnight (ET) on Friday, September 16.
All submissions will be peer-reviewed by the Summit Program Steering Committee, and you will be notified on or around Friday, September 16, if your case is accepted for presentation during a Special Session titled “Challenging Cases in BTC” on Friday, October 14.
If accepted, you will be expected to create a PowerPoint slide presentation for a 5-minute presentation and a 10-minute discussion.
Since an Audience Response System (ARS) will be available at the CCA Summit, your case should include multiple-choice questions integrated into the flow of the presentation so that audience members can weigh in on management decisions during the case discussion.
You are encouraged to prepare a case in consultation with your mentor or a senior member of your healthcare team, with whom you can make your presentation. A senior faculty member will lead a discussion of your case during your presentation, in which you are encouraged to participate actively.
This is an opportunity to share data from your research studies on cholangiocarcinoma (CCA) or other biliary tract cancers with your colleagues. Please see below for the specific categories and the instructions for submitting a poster abstract for presentation during the meeting.
Please submit an abstract of your research project by midnight (ET) on Thursday, September 7th.
All submissions will be peer-reviewed by the Summit Program Steering Committee, and you will be notified on or around Thursday, September 14th, if your poster is accepted for display and/or presentation.
If accepted, you will be expected to create a poster for display.
To sign up for our newsletter or print publications, please enter your contact information below.